SCHEMBL14014378

SCHEMBL14014378

COc1ccc(-c2cnc3c(C(=O)O)cnn3c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.65
ALDH1A1 P00352 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.50
KMT2A Q03164 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
GFER P55789 1/20 0.45
MAPT P10636 4/20 0.45
MEN1 O00255 2/20 0.45
HPGD P15428 1/20 0.45
TDP1 Q9NUW8 2/20 0.45
KDR P35968 3/20 0.45
LMNA P02545 1/20 0.45
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
MAP4K4 O95819 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
PTGS2 P35354 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14014492 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL14014409 0.86 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4710742 0.86 HSD17B10 (0.53) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4272298 0.84 RAB9A (0.61) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL14014486 0.82 MCL1 (0.48) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL14014406 0.82 MCL1 (0.48) KDM4EALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL14014496 0.81 KDM4E (0.56) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4275323 0.81 RAB9A (0.57) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4710751 0.81 KDM4E (0.57) KDM4EALDH1A1SMN1; SMN2KMT2ANPC1
SCHEMBL4708833 0.79 IRAK4 (0.46) KDM4EALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449488-B2 Pyrazolopyrimidines as protein kinase inhibitors SCHERING CORPORATION (US) 2008-11-11 US disclosed
US-7449488-B2 Pyrazolopyrimidines as protein kinase inhibitors SCHERING CORPORATION (US) 2008-11-11 US disclosed
US-7196111-B2 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents SCHERING CORPORATION (US) 2007-03-27 US disclosed
US-7196111-B2 Pyrazolo[1,5a]pyrimidine compounds as antiviral agents SCHERING CORPORATION (US) 2007-03-27 US disclosed